Equillium (EQ) Interest & Investment Income (2018 - 2026)
Equillium (EQ) reported Interest & Investment Income of $309000.0 for Q1 2026, up 78.61% year-over-year from $173000.0 in Q1 2025, and up 1.98% quarter-over-quarter from $303000.0 in Q4 2025.
Equillium (EQ) Interest & Investment Income (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Interest & Investment Income data on file, last reported at $309000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $309000.0, up 78.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $969000.0 (down 13.02% YoY), and the FY2025 annual result was $833000.0, down 39.68% from the prior year.
- Interest & Investment Income grew to $309000.0 in Q1 2026 per EQ's latest filing, from $303000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $639000.0 in Q1 2023 and troughed at $25000.0 in Q1 2022.
- A 5-year average of $310352.9 and a median of $303000.0 in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income surged 2456.0% in 2023, then sank 67.12% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $201000.0 in 2022, then surged by 157.21% to $517000.0 in 2023, then plunged by 53.77% to $239000.0 in 2024, then climbed by 26.78% to $303000.0 in 2025, then rose by 1.98% to $309000.0 in 2026.
- Business Quant data shows EQ's Interest & Investment Income at $309000.0 in Q1 2026, $303000.0 in Q4 2025, and $235000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 309,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 309,000.00 |
| Dec 31, 2025 | 303,000.00 |
| Sep 30, 2025 | 235,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Dec 31, 2024 | 239,000.00 |
| Sep 30, 2024 | 331,000.00 |
| Jun 30, 2024 | 371,000.00 |
| Mar 31, 2024 | 439,000.00 |
| Dec 31, 2023 | 517,000.00 |
| Sep 30, 2023 | 551,000.00 |
| Jun 30, 2023 | 627,000.00 |
| Mar 31, 2023 | 639,000.00 |
| Dec 31, 2022 | 201,000.00 |
| Sep 30, 2022 | 130,000.00 |
| Jun 30, 2022 | 64,000.00 |
| Mar 31, 2022 | 25,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 13,000.00 |